Metadata Search Funding Data Link References Status API Help
Facet browsing currently unavailable
Page 3 of 10761 results
Sort by: relevance publication year
Showing results for ISSN matching 0887-6924

Age-related clinical and biological features of PTEN abnormalities in T-cell acute lymphoblastic leukaemia

JOURNAL ARTICLE published December 2017 in Leukemia

Authors: M Tesio | A Trinquand | P Ballerini | G Hypolite | L Lhermitte | A Petit | N Ifrah | A Baruchel | H Dombret | E Macintyre | V Asnafi

https://doi.org/10.1038/leu.2017.157 Actions

Inhibition of precursor B-cell malignancy progression by toll-like receptor ligand-induced immune responses

JOURNAL ARTICLE published October 2016 in Leukemia

Authors: M Fidanza | A E Seif | A DeMicco | N Rolf | S Jo | B Yin | Y Li | D M Barrett | J Duque-Afonso | M L Cleary | C H Bassing | S A Grupp | G S D Reid

https://doi.org/10.1038/leu.2016.152 Actions

Second primary malignancies in myeloproliferative neoplasms and the role of aspirin

JOURNAL ARTICLE published October 2019 in Leukemia

Authors: Marko Lucijanic | Marko Skelin | Rajko Kusec

https://doi.org/10.1038/s41375-019-0553-2 Actions

Publisher Correction: SIRT7: an influence factor in healthy aging and the development of age-dependent myeloid stem-cell disorders

JOURNAL ARTICLE published December 2021 in Leukemia

Authors: Alexander Kaiser | Martin Schmidt | Otmar Huber | Jochen J. Frietsch | Sebastian Scholl | Florian H. Heidel | Andreas Hochhaus | Jörg P. Müller | Thomas Ernst

https://doi.org/10.1038/s41375-021-01365-4 Actions

Efficacy of dasatinib in conjunction with α-interferon for the treatment of imatinib-resistant and dasatinib-resistant Ph+ acute lymphoblastic leukemia

JOURNAL ARTICLE published September 2009 in Leukemia

Authors: G Visani | P Piccaluga | M Malagola | A Isidori

https://doi.org/10.1038/leu.2009.96 Actions

Unsolved issues in CLL biology and management

JOURNAL ARTICLE published 1 December 2003 in Leukemia

Authors: G Dighiero

https://doi.org/10.1038/sj.leu.2403154 Actions

Treatment of primary CLL cells with bezafibrate and medroxyprogesterone acetate induces apoptosis and represses the pro-proliferative signal of CD40-ligand, in part through increased 15dΔ12,14,PGJ2

JOURNAL ARTICLE published February 2009 in Leukemia

Authors: R E Hayden | G Pratt | N J Davies | F L Khanim | J Birtwistle | J Delgado | C Pearce | T Sant | M T Drayson | C M Bunce

https://doi.org/10.1038/leu.2008.283 Actions

Inv(11)(q21q23) fuses MLL to the Notch co-activator mastermind-like 2 in secondary T-cell acute lymphoblastic leukemia

JOURNAL ARTICLE published September 2008 in Leukemia

Authors: M Metzler | M S Staege | L Harder | D Mendelova | J Zuna | E Fronkova | C Meyer | T Flohr | D Bednarova | J Harbott | T Langer | S Gesk | J Trka | R Siebert | T Dingermann | R Marschalek | C Niemeyer | W Rascher

https://doi.org/10.1038/leu.2008.50 Actions

Quantitative monitoring of cell clones carrying point mutations in the BCR–ABL tyrosine kinase domain by ligation-dependent polymerase chain reaction (LD–PCR)

JOURNAL ARTICLE published October 2008 in Leukemia

Authors: S Preuner | D Denk | F Frommlet | M Nesslboeck | T Lion

https://doi.org/10.1038/leu.2008.97 Actions

Retinoid/arsenic combination therapy of promyelocytic leukemia: induction of telomerase-dependent cell death

JOURNAL ARTICLE published 1 October 2005 in Leukemia

Authors: I Tarkanyi | C Dudognon | J Hillion | F Pendino | M Lanotte | J Aradi | E Ségal-Bendirdjian

https://doi.org/10.1038/sj.leu.2403923 Actions

Long-term results in children with AML: NOPHO-AML Study Group – report of three consecutive trials

JOURNAL ARTICLE published December 2005 in Leukemia

Authors: S O Lie | J Abrahamsson | N Clausen | E Forestier | H Hasle | L Hovi | G Jonmundsson | L Mellander | M A Siimes | M Yssing | B Zeller | G Gustafsson | on behalf of the Nordic Society of Pediatric Hematology and Oncology (NOPHO)

https://doi.org/10.1038/sj.leu.2403962 Actions

MCL1 regulates AML cells metabolism via direct interaction with HK2. Metabolic signature at onset predicts overall survival in AMLs’ patients

JOURNAL ARTICLE published August 2023 in Leukemia

Research funded by Ministero dell'Istruzione, dell'Università e della Ricerca (2017WWB99Z,2017WXR7ZT_004) | Associazione Italiana per la Ricerca sul Cancro (#21267)

Authors: Gianfranco Catalano | Alessandra Zaza | Cristina Banella | Elvira Pelosi | Germana Castelli | Elisabetta de Marinis | Ariela Smigliani | Serena Travaglini | Tiziana Ottone | Mariadomenica Divona | Maria Ilaria Del Principe | Francesco Buccisano | Luca Maurillo | Emanuele Ammatuna | Ugo Testa | Clara Nervi | Adriano Venditti | Maria Teresa Voso | Nelida Ines Noguera

https://doi.org/10.1038/s41375-023-01946-5 Actions

14-3-3ζ binds the proteasome, limits proteolytic function and enhances sensitivity to proteasome inhibitors

JOURNAL ARTICLE published March 2018 in Leukemia

Authors: Y Gu | K Xu | C Torre | M Samur | B G Barwick | M Rupji | J Arora | P Neri | J Kaufman | A Nooka | L Bernal-Mizrachi | P Vertino | S-Y Sun | J Chen | N Munshi | H Fu | J Kowalski | L H Boise | S Lonial

https://doi.org/10.1038/leu.2017.288 Actions

Prevalence of UBA1 mutations in MDS/CMML patients with systemic inflammatory and auto-immune disease

JOURNAL ARTICLE published September 2021 in Leukemia

Authors: Lin-Pierre Zhao | Berenice Schell | Marie Sébert | Rathana Kim | Pierre Lemaire | Maxime Boy | Stephanie Mathis | Lise Larcher | Clémentine Chauvel | Mohamed Bedis Dhouaieb | Valéria Bisio | Claude Preudhomme | Alice Marceau-Renaut | Raphaël Itzykson | Arsène Mekinian | Olivier Fain | Antoine Toubert | Pierre Fenaux | Nicolas Dulphy | Emmanuelle Clappier | Lionel Adès

https://doi.org/10.1038/s41375-021-01353-8 Actions

Glasdegib plus intensive or non-intensive chemotherapy for untreated acute myeloid leukemia: results from the randomized, phase 3 BRIGHT AML 1019 trial

JOURNAL ARTICLE published October 2023 in Leukemia

Authors: Mikkael A. Sekeres | Pau Montesinos | Jan Novak | Jianxiang Wang | Deepa Jeyakumar | Benjamin Tomlinson | Jiri Mayer | Erin Jou | Tadeusz Robak | David C. Taussig | Hervé Dombret | Akil Merchant | Naveed Shaik | Thomas O’Brien | Whijae Roh | Xueli Liu | Wendy Ma | Christine G. DiRienzo | Geoffrey Chan | Jorge E. Cortes

https://doi.org/10.1038/s41375-023-02001-z Actions

An “off-the-shelf” CD2 universal CAR-T therapy for T-cell malignancies

JOURNAL ARTICLE published December 2023 in Leukemia

Research funded by U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA210084,CA091842) | U.S. Department of Health & Human Services | National Institutes of Health (CA171963)

Authors: Jingyu Xiang | Jessica M. Devenport | Alun J. Carter | Karl W. Staser | Miriam Y. Kim | Julie O’ Neal | Julie K. Ritchey | Michael P. Rettig | Feng Gao | Garrett Rettig | Rolf Turk | Byung Ha Lee | Matthew L. Cooper | John F. DiPersio

https://doi.org/10.1038/s41375-023-02039-z Actions

Discovery of a BTK/MNK dual inhibitor for lymphoma and leukemia

JOURNAL ARTICLE published January 2016 in Leukemia

Authors: H Wu | C Hu | A Wang | E L Weisberg | Y Chen | C-H Yun | W Wang | Y Liu | X Liu | B Tian | J Wang | Z Zhao | Y Liang | B Li | L Wang | B Wang | C Chen | S J Buhrlage | Z Qi | F Zou | A Nonami | Y Li | S M Fernandes | S Adamia | R M Stone | I A Galinsky | X Wang | G Yang | J D Griffin | J R Brown | M J Eck | J Liu | N S Gray | Q Liu

https://doi.org/10.1038/leu.2015.180 Actions

miR-9 is a tumor suppressor in pediatric AML with t(8;21)

JOURNAL ARTICLE published May 2014 in Leukemia

Authors: S Emmrich | J E Katsman-Kuipers | K Henke | M E Khatib | R Jammal | F Engeland | F Dasci | C M Zwaan | M L den Boer | L Verboon | J Stary | A Baruchel | V de Haas | A A Danen-van Oorschot | M Fornerod | R Pieters | D Reinhardt | J H Klusmann | M M van den Heuvel-Eibrink

https://doi.org/10.1038/leu.2013.357 Actions

Evidence for the interaction of imatinib at the transport-substrate site(s) of the multidrug-resistance-linked ABC drug transporters ABCB1 (P-glycoprotein) and ABCG2

JOURNAL ARTICLE published February 2008 in Leukemia

Authors: S Shukla | Z E Sauna | S V Ambudkar

https://doi.org/10.1038/sj.leu.2404897 Actions

Combination p53 activation and BCL-xL/BCL-2 inhibition as a therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemia

JOURNAL ARTICLE published 10 April 2024 in Leukemia

Authors: Hayden L. Bell | Helen J. Blair | Samantha J. Jepson Gosling | Martin Galler | Daniel Astley | Anthony V. Moorman | Olaf Heidenreich | Gareth J. Veal | Frederik W. van Delft | John Lunec | Julie A. E. Irving

https://doi.org/10.1038/s41375-024-02241-7 Actions
Feedback: support@crossref.org